MarketLens
Sign Up

Why Are Analysts Bullish on Strata Critical Medical (SRTA) Despite Cathie Wood's Exit

4 months ago
SHARE THIS ON:

Why Are Analysts Bullish on Strata Critical Medical (SRTA) Despite Cathie Wood's Exit

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News3 weeks ago

Azenta: Needs To Overcome A Few Hurdles If The Rally Is To Continue

Azenta (AZTA) shares have doubled since a multi-year low in May 2026, but chart patterns suggest the rally could unwind. The bull case depends on hitting financial targets, which remains uncertain.
Stock News4 weeks ago

Astrana Health: 81% Full-Risk And Profitable

Astrana Health trades at a 46% discount to peers, with G&A costs down to 5.57% of revenue from 7.75%, after its Care Enablement platform quadrupled third-party revenue year-over-year.
Stock News1 months ago

Wall Street Analysts Predict a 60% Upside in Strata Critical Medical, Inc. (SRTA): Here's What You Should Know

Strata Critical Medical (SRTA) has a consensus price target implying 60% upside, driven by upward earnings estimate revisions. However, the metric's reliability is limited, and near-term gains depend ...

Breaking News

View All →

Top Headlines

View More →
Stock News56 minutes ago

Palantir Technologies Showcases Sovereign AI Wins With NVIDIA, Cisco and FAA

Stock News1 hour ago

Here's Why Meta Platforms (META) Fell More Than Broader Market

Stock News1 hour ago

IBM (IBM) Dips More Than Broader Market: What You Should Know

Stock News1 hour ago

Tesla (TSLA) Falls More Steeply Than Broader Market: What Investors Need to Know

Stock News1 hour ago

Nvidia Returned $26 Billion to Shareholders Last Quarter Alone. Here's What That Buys You as an Investor.